2008
DOI: 10.1016/j.cellbi.2008.04.023
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of lipopolysaccharide‐mediated rat alveolar macrophage activation in vitro by antiflammin‐1

Abstract: Antiflammin-1 (AF-1) is a synthetic nonapeptide with a similar sequence to the conserved sequence of CC10 secreted by lung Clara cells. Studies suggest that it is potent inhibitor of inflammation. We investigated the effects and possible mechanisms of AF-1 on LPS-induced alveolar macrophage (AM) activation in vitro. AMs harvested from the BALF of Sprague-Dawley (SD) rat were treated with various concentrations of AF-1 both simultaneously and after LPS stimulation. The concentrations of the cytokines IL-1beta, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 40 publications
0
9
0
Order By: Relevance
“…LPS-TLR4 signaling is one of the most important inflammatory response signal pathways (25). As AMs are the major effector cells that participate in the initiation and development of ALI (4,5,26), modulating the excessive inflammatory response to pathogenassociated molecular patterns in AMs during systemic inflammatory response syndrome is a therapeutic target for treating ALI/ARDS. PALM3 is a novel interactive partner of single immunoglobulin IL-1 receptor-related molecule (SIgIRR) and may function as an adaptor in LPS-TLR4 signaling (19).…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…LPS-TLR4 signaling is one of the most important inflammatory response signal pathways (25). As AMs are the major effector cells that participate in the initiation and development of ALI (4,5,26), modulating the excessive inflammatory response to pathogenassociated molecular patterns in AMs during systemic inflammatory response syndrome is a therapeutic target for treating ALI/ARDS. PALM3 is a novel interactive partner of single immunoglobulin IL-1 receptor-related molecule (SIgIRR) and may function as an adaptor in LPS-TLR4 signaling (19).…”
Section: Discussionmentioning
confidence: 99%
“…Rat AMs were routinely grown in ham's F12 medium supplemented with 10% fetal bovine serum and seeded in 6-well plates at a density of 1x10 5 cells/well. After the cell growth reached 50-60% confluence, rat AMs were treated with 0.5 µg/ml LPS (Escherichia coli 0111: B4; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany) as described previously to simulate ALI in an in vitro model (4,5). The total RNA and protein were isolated before the treatment with LPS and at 3, 6, 12, 24 and 48 h following the addition of LPS for the analysis of PALM3 expression.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…In the present study, continuous treatment with AF-1 (2 mg · kg -1 ) starting on Day 0 significantly alleviated the inflammation on Day 7 and the collagen deposition on Day 28 in the bleomycin-induced model of lung injury (Figures  2 and 3). The anti-inflammatory activity of AF-1 in this model may be due to its blockade of neutrophil trafficking, suppression of the activation of macrophages and reduction of the production and release of inflammatory mediators [11,12]. …”
Section: Discussionmentioning
confidence: 99%